Subclonal TP53 copy number is associated with prognosis in multiple myeloma.
暂无分享,去创建一个
G. Morgan | R. Houlston | W. Gregory | M. Drayson | M. Jenner | F. Davies | G. Cook | G. Jackson | D. Cairns | S. Savola | M. Kaiser | David C. Johnson | A. Sherborne | V. Shah | R. Owen | Amy L. Sherborne | L. Chiecchio | S. Ellis | Amy Price | F. Aldridge | Julie Howard-Reeves | F. Begum | J. Kendall | A. Price | Vallari Shah | Sidra Ellis | G. Jackson | Julie Howard‐Reeves
[1] P. Lønning,et al. Effects of concomitant inactivation of p53 and pRb on response to doxorubicin treatment in breast cancer cell lines , 2017, Cell Death Discovery.
[2] N. McGranahan,et al. Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future , 2017, Cell.
[3] D. Landau,et al. Genomic complexity of multiple myeloma and its clinical implications , 2017, Nature Reviews Clinical Oncology.
[4] P. Sicinski,et al. Cell cycle proteins as promising targets in cancer therapy , 2017, Nature Reviews Cancer.
[5] Thomas Yu,et al. Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data. , 2017, The Lancet. Oncology.
[6] A. López-Guillermo,et al. Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia. , 2015, Blood.
[7] Gordon Cook,et al. Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] G. Morgan,et al. A molecular diagnostic approach able to detect the recurrent genetic prognostic factors typical of presenting myeloma , 2014, Genes, chromosomes & cancer.
[9] G. Morgan,et al. A TC classification-based predictor for multiple myeloma using multiplexed real-time quantitative PCR , 2013, Leukemia.
[10] P. Sonneveld,et al. Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders , 2012, Haematologica.
[11] M. Pencina,et al. On the C‐statistics for evaluating overall adequacy of risk prediction procedures with censored survival data , 2011, Statistics in medicine.
[12] Chin-Tsang Chiang,et al. Estimation methods for time‐dependent AUC models with survival data , 2009 .